POSTER: AML-229 Efficacy and Safety of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in the CADENZA Study.
Year: 2025
Type: article
Authors: Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos, Andrew A. Lane, Luca Mazzarella, David Andrew Sallman, Matthew Ulrickson, Gary J. Schiller, Harry Paul Erba, Eunice S.Wang, Roland B.Walter, Eric Deconinck, Ahmed M. Aribi, Ollivier Legrand, Delphine Lebon, Giovanni Martinelli, Daniel J. DeAngelo, Yining Du, Jalaja Potluri, Naval Guastad Daver
Institutions: The University of Texas MD Anderson Cancer Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Hospital Universitari i Politècnic La Fe, Dana-Farber Cancer Institute, European Institute of Oncology, Moffitt Cancer Center, Banner MD Anderson Cancer Center, University of California, Los Angeles, Duke University, Roswell Park Comprehensive Cancer Center, Fred Hutch Cancer Center, Centre Hospitalier Universitaire de Besançon, City Of Hope National Medical Center, City of Hope, Hôpital Saint-Antoine, Centre Hospitalier Universitaire Amiens-Picardie, AbbVie (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413782196